IM Cannabis Reports Fiscal 2020 Results; Provides Preliminary Q1 Results and Q2 Outlook

Author's Avatar
Apr 23, 2021
  • Q4 2020: revenues of $4.9 million and gross margin of 57%1; FY 2020: revenues of $15.9 million and gross margin of 55%1.
  • Preliminary unaudited Q1 2021 revenues expected to be in the range of $8.5 - $9.0 million; gross margin expected to be in the range of 50% to 55%.
  • Q2 2021 revenues expected to be in the range of $17 million - $19 million from continued growth in Israel, resumption of product shipments and growth of revenue in Germany, and inclusion of Trichome operations in the Company's financial results